Abstract
The health-promoting effects of physical activity to prevent and treat metabolic disorders are numerous. However, the underlying molecular mechanisms are not yet completely deciphered. In recent years, studies have referred to the liver as an endocrine organ, since it releases specific proteins called hepatokines. Some of these hepatokines are involved in whole body metabolic homeostasis and are theorized to participate in the development of metabolic disease. In this regard, the present review describes the role of Fibroblast Growth Factor 21, Fetuin-A, Angiopoietin-like protein 4, and Follistatin in metabolic disease and their production in response to acute exercise. Also, we discuss the potential role of hepatokines in mediating the beneficial effects of regular exercise and the future challenges to the discovery of new exercise-induced hepatokines.
| Original language | English |
|---|---|
| Pages (from-to) | E11-E24 |
| Number of pages | 14 |
| Journal | American Journal of Physiology - Endocrinology and Metabolism |
| Volume | 317 |
| Issue number | 1 |
| Early online date | 21 Jun 2019 |
| DOIs | |
| Publication status | Published - 1 Jul 2019 |
Keywords
- exercise
- hepatokines
- liver
- metabolic diseases